Zacks: Analysts Expect Kronos Worldwide, Inc. (NYSE:KRO) Will Post Quarterly Sales of $427.54 Million
Equities research analysts expect Kronos Worldwide, Inc. (NYSE:KRO) to report sales of $427.54 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Kronos Worldwide’s earnings, with the highest sales estimate coming in at $437.00 million and the lowest estimate coming in at $418.07 million. Kronos Worldwide reported sales of $410.30 million during the same quarter last year, which would suggest a positive year over year growth rate of 4.2%. The business is expected to issue its next quarterly earnings results on Wednesday, November 6th.
On average, analysts expect that Kronos Worldwide will report full-year sales of $1.72 billion for the current fiscal year, with estimates ranging from $1.70 billion to $1.75 billion. For the next fiscal year, analysts anticipate that the firm will report sales of $1.78 billion, with estimates ranging from $1.76 billion to $1.80 billion. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that follow Kronos Worldwide.
Kronos Worldwide (NYSE:KRO) last issued its quarterly earnings results on Wednesday, August 7th. The specialty chemicals company reported $0.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.06). Kronos Worldwide had a return on equity of 13.56% and a net margin of 6.93%. The business had revenue of $484.50 million during the quarter, compared to analyst estimates of $465.00 million. During the same period in the previous year, the business posted $0.67 earnings per share. The firm’s quarterly revenue was up 2.7% on a year-over-year basis.
NYSE:KRO traded up $0.09 during mid-day trading on Thursday, reaching $11.75. The company’s stock had a trading volume of 130,620 shares, compared to its average volume of 188,787. The company’s fifty day simple moving average is $11.84 and its two-hundred day simple moving average is $13.02. The company has a debt-to-equity ratio of 0.61, a current ratio of 4.94 and a quick ratio of 2.98. Kronos Worldwide has a twelve month low of $9.65 and a twelve month high of $16.13. The stock has a market cap of $1.35 billion, a P/E ratio of 6.64 and a beta of 2.03.
In other news, Vice Chairman Robert D. Graham acquired 5,000 shares of Kronos Worldwide stock in a transaction dated Friday, August 9th. The shares were acquired at an average cost of $10.75 per share, with a total value of $53,750.00. Following the purchase, the insider now directly owns 16,000 shares of the company’s stock, valued at approximately $172,000. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Andrew B. Nace acquired 6,000 shares of Kronos Worldwide stock in a transaction dated Friday, August 9th. The stock was purchased at an average cost of $11.21 per share, for a total transaction of $67,260.00. Following the completion of the purchase, the insider now directly owns 4,475 shares in the company, valued at $50,164.75. The disclosure for this purchase can be found here. Insiders bought a total of 16,500 shares of company stock worth $177,285 over the last ninety days. Corporate insiders own 0.09% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in KRO. Tolleson Wealth Management Inc. lifted its position in Kronos Worldwide by 7.9% during the 2nd quarter. Tolleson Wealth Management Inc. now owns 20,595 shares of the specialty chemicals company’s stock worth $316,000 after acquiring an additional 1,500 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Kronos Worldwide by 1.3% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 126,358 shares of the specialty chemicals company’s stock worth $1,936,000 after acquiring an additional 1,601 shares in the last quarter. Bank of Montreal Can lifted its position in Kronos Worldwide by 22.2% during the 2nd quarter. Bank of Montreal Can now owns 13,420 shares of the specialty chemicals company’s stock worth $205,000 after acquiring an additional 2,434 shares in the last quarter. Cozad Asset Management Inc. lifted its position in Kronos Worldwide by 5.4% during the 2nd quarter. Cozad Asset Management Inc. now owns 87,909 shares of the specialty chemicals company’s stock worth $1,347,000 after acquiring an additional 4,465 shares in the last quarter. Finally, Aperio Group LLC lifted its position in Kronos Worldwide by 11.6% during the 2nd quarter. Aperio Group LLC now owns 66,865 shares of the specialty chemicals company’s stock worth $1,024,000 after acquiring an additional 6,973 shares in the last quarter. 19.71% of the stock is currently owned by institutional investors and hedge funds.
Kronos Worldwide Company Profile
Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. It produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.